Torasemid
Generic name
Torasemid
Brand name
ATC Code
C03CA04
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information is present at this moment.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Maintenance of residual diuresis in severe renal failure |
|---|
|
| Cardiac edema and/or effusions due to heart failure |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
HIGH-CEILING DIURETICS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Sulfonamides, plain | ||
|---|---|---|
| C03CA02 | ||
| C03CA01 | ||
| Aryloxyacetic acid derivatives | ||
|---|---|---|
| C03CC01 | ||
References
- Hexal AG, SmPC, Torasemid HEXAL® 50/100/200 mg Tabletten (58015.04.00), 11/2014
- MEDA Pharma GmbH & Co. KG, SmPC, Unat® RR/Cor 2,5/5/10 mg Tabletten (9857.00.00), 12/2016
Changes
Therapeutic Drug Monitoring
Overdose
